PTX 0.00% 3.9¢ prescient therapeutics limited

Daily happenings?., page-368

  1. 7,937 Posts.
    lightbulb Created with Sketch. 3399
    That's not exactly true. We have CellPryme "supposedly" being evaluated by several prospective partners.

    The sound of crickets from management is in stark contrast, though, to the claims that it was a "clinic-ready" technology.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.